6 & 6 a * , ( / a : 1 , * ( - / ! 6 ... · Вакцинация против ящура и...
TRANSCRIPT
Вакцинация против ящура и послевакцинационный мониторинг
Руководство
Редакторы: Самиа Метвалли, Сюзанна Мюнстерманн
Авторы: Джанкарло Феррари, Дэвид Пейтон, Серджо Дуффи, Крис Бартелс, Тео Найт-Джонс
ИзданоПродовольственной и сельскохозяйственной организацией Объединенных Наций
ии Всемирной организацией по охране здоровья животных
2020
Foot and mouth disease vaccination and post-vaccination monitoring
4
9
4
Aphthovirus Picornaviridae
и
1.1
1.2
1.3
et al
1.4
a
b
a
b
c
d
e
1.5
a
b
1.6
(19-23)
2.1
a)
b)
a
b
20
2.2
2.3
21
2.4
22
2.5
0
n
n
23
2.6
3.1
3.2
+++ +
+ +++
++ +
et al
et al
et al
T50 T50 T95
O 1.6 1.1 1.7 2.1
A 1.4 1.3 1.6 2.1
1.7 0.4 2.0 2.3
1.5 1.4 1.6 2.1
3.3
A 24 Cruzeiro 1.9
A Argentina 2001 2.2
O1 Campos 2.1
C3 Indaial 2.2
et al
T50 T50 T95
A 1.45 1.326 1.56 2.567
T50T95
A1 A2
1 1.81 1.34
2 1.51 0.90
3 1.20 1.04
4 1.34 1.20
5 1.81 2.11
P*
A1 1 in 34 1.53 0.73 0.125
A2 1 in 21 1.32 0.48 0.529
a
b
c
3.4
3.5
a
b
c
a
b
c
a
b
c
d
e≤
3.6
4.1 4.2
RU RV RU
RU
RV
RV RU
4.3
4.4
4.5
4.6
A
B
C
D
1. Alexandersen S., Zhang Z., Donaldson A.I. & Garland A.J.M.(2003). – The pathogenesis and diagnosis of foot-and-mouth disease. J. comp. Pathol., 129, 1–36. doi: 10.1016/s0021- 9975(03)00041-0.
2. Armitage P. (1971). – Statistical methods in medical research.
3. Barnett P.V., Statham R.J., Vosloo W. & Haydon D.T. (2003).– Foot-and-mouth disease vaccine potency testing:determination and statistical validation of a model using aserological approach. Vaccine, 21, 3240–3248. doi: 10.1016/S0264-410X(03)00219-6.
4. Barteling S.J., Yadin H. & Sutmoller P. (2004). – Discussionpaper on guidelines for control of Foot-and-MouthDisease (FMD) vaccine quality and performance in the
commissions/docs/greece04/ App19.pdf.
5. Bennett S., Woods T., Liyanage W.M. & Smith D.L. (1991). – A
in developing countries. World Health Stat. Q., 44, 98–106.
competition ELISA to the measurement of anti-FMDV
immunization coverage: methods and processes. Bull. WorldHealth Organ., 87, 535–541. doi: 10.2471/BLT.08.053819.
in immunization programmes. Epidemiol. Rev., 18, 99–117.doi: 10.1093/oxfordjournals.epirev.a017931.
mass serology. J. virol. Methods, 107, 89–98. doi: 10.1016/S0166-0934(02)00196-9.
FMD vaccines. Vaccine, 17, 1767–1771. doi: 10.1016/j.vaccine.2009.08.039.
reproduction ratio and time-space analysis of a foot-and-mouth disease epidemic in Peru in 2004. Transbound. emerg.Dis., 55, 284–92. doi: 10.1111/j.1865-1682.2008.01023.x.
14. Fleiss J.L. (1981). – Statistical methods for rates and
16. Garland A.J. (1999). – Vital elements for the successful control Vaccine, 17,
1760– 1766.
virus. 3. Evaluation after infection and vaccination. Epidemiol.Infect., 99, 733–744. doi: 10.1017/ S0950268800066590.
IMA J. math. appl. Med. Biol., 14
19. Hayes R.J. & Bennett S. (1999). – Simple sample size calculation for cluster randomized trials. Int. J. Epidemiol., 28,319–326.doi:10.1093/ije/28.2.319.
to assess immunization coverage: a review of experience withBull. World Health Organ.,
60,253–260.
(53-55)
54
G. & Dekker A. (2008). – Foot-and-mouth disease vaccine
valency, fractionation method, and virus culture on thedose-response curve in cattle. Vaccine, 26, 6317–6321. doi:10.1016/j.vaccine.2008.09.021.
22. Jamal S.M., Shah S.I., Ali Q., Mehmood A., Afzal M. & Dekker A. (2013). – Proper quality control of formulated foot- and-mouth disease vaccines in countries with prophylactic vaccinationis necessary. Transbound. emerg. Dis., 61, 483–489. doi:
epidemic: stochastic dispersal in a heterogeneous landscape.Science, 294 (5543), 813–817. doi: 10.1126/science.1065973.
against foot-and-mouth disease. Br. vet. J., 151, 379–389. doi:10.1016/S0007-1935(95)80127-8.
Veterinary and human vaccine evaluation methods. Proc. biol.Sci., 281PMID: 24741009.
of foot-and-mouth disease vaccine effectiveness inTurkey. Vaccine, 32 (16), 1848–1855. doi: 10.1016/j.vaccine.2014.01.071.
immunity and coverage: modelling population protectionagainst foot-and-mouth disease in Turkishcattle. Sci. Rep., 6,22121. doi: 10.1038/srep22121.
Sessionofthe Research Groupofthe Standing Technical
protection from virus challenge for the assessment of thepotency of polyvalent aphtovirus vaccines in Argentina. Vaccine,26 (51), 6577–6586. doi: 10.1016/j.vaccine.2008.09.033.
Lamorde A.G. (1983). – The control of foot and mouth disease Rev. Sci. Tech. Off.
Int. Epiz., 2 (3), 771–780.
of calves to vaccination against foot and mouth disease. J. Hyg. (Camb.), 92, 105–116. doi: 10.1017/S0022172400064081.
Epidemiol.Rev., 10, 212–241.
V.M., Palma E.L. & Thomson G.R. (2005). – Selection of footand mouth disease vaccine strains – a review. Rev. Sci. Tech.Off. Int. Epiz., 24 (3), 981–93.
36. Pay T.W.F. & Hingley P.J. (1992). – Foot and mouth diseasevaccine potency tests in cattle: the interrelationship of
protection from challenge. Vaccine, 10, 699–706. doi:10.1016/0264-410X(92)90092-X.
assessment of foot-and-mouth disease vaccine potency and
neutralization tests. Vaccine, 28, 6235–6241. doi: 10.1016/j.vaccine.2010.07.012.
Vet. Rec., 170, 637–639. doi: 10.1136/vr.e4180.
Endurance of immunity against foot-and-mouth disease incattle after three consecutive annual vaccinations. Res. vet.Sci., 49, 236–242.
responses in Dutch cattle vaccinated with foot-and-mouth
Am. J. vet. Res.,30, 2125–2159.
test to evaluate immunity in potency tests of foot-and-mouthdisease vaccines. J. Immunol. Methods, 124, 111–119.
and mouth disease. Epidemiol. Infect., 116, 363–371. doi:10.1017/S0950268800052699.
animal health systems through improved control of major
of Diagnostic Tests and Vaccines for Terrestrial Animals, 2014.
www.oie.int/manual-of-diagnostic-tests-and-vaccines-for- terrestrial-animals/.
terrestrial-code/.
(59-65)
1.
R0). R0
R0
R0
Rv
R0
R0
fh
f h R0
R0)f
h)
f
h)
2.5
4
5
2.
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………............
……………………………………………………............................ …………………………....................................................................... …………………………………………………….....................................................................
….............. …................. …....................... ……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………......
………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….....................
(4) (5) (6)
………………………………................................................................................................................. …....... …....... …........
…………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………...............
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………....
.........................................................................................................................................................................................................................................................................................................................................................................................................
…....... …....... …........ ……………………………………………………………………...................................................
………………………………..................................................................................................... …....... …....... …........
………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………..
……………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….
62
OVC
.
2.
ORD
64
RCV
RMV
RUV
.
3.
65
1.
2.
t0 tt t3
n 2 p p)
e2
ni
N
4.
n 2 49
2
~
69
p a
n
a
n
CI p SE
SE(pp
n
CIp p)
n
a n
p 49
SE (p
5 (95) 2
95
5 52
95
2
95
5
95
5
95 246
44
95 62
5
95
65
95
5
95
95
CI
CI pp p) ( )
n N
N
69
( ) N
3.
D
D
D s cluster
s srs
s
(rho
D rho
(rho
rho S b
S b w
S b S w
rho
rho D m
n p)
e2
D m rho
rho
rho
rho
n n D
n
C).
n m
rhorho
D n rhorho rho
n
rhorho
rho
C2 p p) x De2 x m
C2 p p) m rhoe2 x m
rho
C2 p p) m rho
e2 x m
C
2
2
C
p h
h
hh).
CI p SE
SE c h p m h + p2 mh
h c(c
p h
mh
~
2
Mh
wh Mh M
wh h
h).
mh yh2
h mhyh2
h
6
2 9
4
4 6
5 64
6 49
6
6
9 64
5 25
49
4
64
6
5 25
9
64
5 25
9
64
6
22 49
64
24 49
25 9
26 5 25
Mh mh yh
6
2 9
4
4 6
5
6
6
569 6
9
25 5
4
45
55 6
5
9
5
9
6
22
24 26
25 9
26 5
Mh(h mh h
Mh mh yh ph wh) phwh
6
2 9
4
4 6
5
6
6
569 6
9
25 5
4
45
55 6
5
9
5
9
6
22
24 26
25 9
26 5
SE c 2hw p mhw hw + p2 m hw
m c(c
mhw wh (nhw ph hw (ph
CI
SE 2
0.041
4.
mhw yhw m2hw y2
hw mhwyhw
2.94
2 6.55
4.94
4.94 2.96
9
6.45 64.96
592.24
22
42.25
n 2 p p)e2
n N( )
(
D
N
N
n p)
p
n 2
2
ni
( () ) n
2
n
259
~SE(p
CI
1.
R R
RR
R R
2.
978-92-5-131765-5 978-92-95115-27-9
I5975RU/1/11.19
ISBN 978-92-5-131765-5
9 7 8 9 2 5 1 3 1 7 6 5 5